BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Ubiquigent Ltd.

Headquarters: Dundee, Scotland, United Kingdom
Year Founded: 2009
Status: Private

BioCentury | Mar 12, 2024
Deals

Deal report: Boehringer-Sosei pursuing new schizophrenia target

Plus: Gilead- Merus to develop trispecific T cell engagers for cancer, and Armatus-Solid collab
BioCentury | Aug 29, 2023
Management Tracks

Crossover-backed Arbor names Tamboli CFO

Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more
BioCentury | Nov 8, 2022
Management Tracks

BMS’ Rutstein joins Daiichi as head of oncology

Plus new CMO at Boehringer Ingelheim, and updates from Repertoire, Atsena, TAAV and more
BioCentury | Feb 20, 2021
Product Development

BMS turns to mechanistic diversity in early oncology pipeline

BMS has holes to fill with upcoming patent expirations
BioCentury | Aug 17, 2018
Financial News

Ubiquigent raises undisclosed venture round

BioCentury | Nov 24, 2014
Company News

Ubiquigent, University of Dundee deal

BioCentury | Nov 10, 2014
Company News

Ubiquigent board of directors update

BioCentury | Sep 23, 2013
Financial News

Ubiquigent completes venture financing

BioCentury | Mar 8, 2010
Financial News

Ubiquigent completes venture financing

Items per page:
1 - 9 of 9
Help Center
Username
Request Training
Submit Data Correction
Ask a Question